U.S. Markets closed

Cosmos Holdings Inc. (COSM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
4.2200+0.2100 (+5.24%)
At close: 3:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.0100
Open4.0100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range4.0100 - 4.2300
52 Week Range2.0100 - 7.7700
Volume28,926
Avg. Volume12,755
Market Cap66.324M
Beta (5Y Monthly)1.08
PE Ratio (TTM)N/A
EPS (TTM)-0.0630
Earnings DateApr 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share
    GlobeNewswire

    Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share

    CEO has converted $4.0 million of the Company’s debt to date; the conversion price represents a premium to marketCHICAGO, July 26, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has further reduce

  • Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share
    GlobeNewswire

    Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share

    The conversion price represents a premium to marketCHICAGO, July 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications and an extensive, established European Union distribution network, is pleased to announce that Mr. Greg Siokas, Chief Executive Officer, has further reduced the debt of the Company by converting an additional $1.0 mil

  • Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria
    GlobeNewswire

    Cosmos Holdings Signs Exclusive Distribution Agreement with Mediprovita GbR for Launch of Sky Premium Life Products in Germany and Austria

    First Phase Launches Sky Premium Life Products on Amazon and eBay; Second Phase Launch Includes Brick & Mortar Stores Continues to Expand its Network of European Distribution Partners; Plans to Enter into Additional European, Asian and New Global Markets in 2H 2021 CHICAGO, July 08, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQX: COSM), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutraceuticals, OTC medications an